BPC-157 Counteracts Both NO Blockers and NO Donors' Effects on Stomach and Blood Pressure
BPC-157 counteracted the harmful effects of both NO blocker L-NAME and NO donor L-arginine on stomach mucosa and blood pressure, confirming its NO-modulating role.
Quick Facts
What This Study Found
BPC-157 counteracted both L-NAME (NO blocker) and L-arginine (NO donor) effects on gastric mucosa and blood pressure, confirming its role as an NO system modulator.
Key Numbers
How They Did This
Rats challenged with ethanol-induced gastric lesions and IV blood pressure measurements while receiving L-NAME, L-arginine, or combinations with BPC-157 at two doses.
Why This Research Matters
BPC-157's ability to normalize NO signaling in both directions explains its broad protective effects across many organ systems.
The Bigger Picture
This NO-modulating property is now considered central to BPC-157's mechanism, explaining how it protects the gut, blood vessels, heart, and other tissues.
What This Study Doesn't Tell Us
Animal study with pharmacological NO manipulation. The doses of L-NAME used create extreme NO blockade not seen physiologically.
Questions This Raises
- ?How does BPC-157 sense and respond to NO imbalance in either direction?
- ?Is the NO modulation mechanism specific to BPC-157 or shared by other gastric peptides?
Trust & Context
- Key Stat:
- Bidirectional NO correction BPC-157 countered both L-NAME (NO blocker) and L-arginine (NO booster) effects on stomach and blood pressure
- Evidence Grade:
- Moderate animal evidence with clear pharmacological demonstration of dual-direction NO modulation.
- Study Age:
- Published in 1997, establishing NO modulation as a key BPC-157 mechanism.
- Original Title:
- The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.
- Published In:
- European journal of pharmacology, 332(1), 23-33 (1997)
- Authors:
- Sikirić, P(10), Seiwerth, S(42), Grabarević, Z(9), Rucman, R, Petek, M, Jagić, V, Turković, B, Rotkvić, I, Mise, S, Zoricić, I, Konjevoda, P, Perović, D, Jurina, L, Separović, J, Hanzevacki, M, Artuković, B, Bratulić, M, Tisljar, M, Gjurasin, M, Miklić, P, Stancić-Rokotov, D, Slobodnjak, Z, Jelovac, N, Marović, A
- Database ID:
- RPEP-00431
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is nitric oxide's role?
NO is a critical signaling molecule that dilates blood vessels, protects the stomach lining, and regulates inflammation. Both too much and too little NO causes harm. BPC-157 appears to maintain optimal NO balance.
Why is bidirectional modulation special?
Most drugs either block or boost NO. BPC-157 does neither exclusively — it corrects NO imbalances in whichever direction is needed. This adaptive response is unusual and helps explain its broad therapeutic profile.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00431APA
Sikirić, P; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Konjevoda, P; Perović, D; Jurina, L; Separović, J; Hanzevacki, M; Artuković, B; Bratulić, M; Tisljar, M; Gjurasin, M; Miklić, P; Stancić-Rokotov, D; Slobodnjak, Z; Jelovac, N; Marović, A. (1997). The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.. European journal of pharmacology, 332(1), 23-33.
MLA
Sikirić, P, et al. "The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.." European journal of pharmacology, 1997.
RethinkPeptides
RethinkPeptides Research Database. "The influence of a novel pentadecapeptide, BPC 157, on N(G)-..." RPEP-00431. Retrieved from https://rethinkpeptides.com/research/sikiric-1997-the-influence-of-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.